JUL 2014 ARTICLE LIST >>
PharmaTutor (July- 2014)
ISSN: 2347 - 7881
Received On: 30/04/2014; Accepted On: 07/05/2014; Published On: 01/07/2014
AUTHORS: R.A Tamboli, V.C. Chauhan, M.M. Pathan, S.K. Tirgar, D.A. Shah, R.R. Parmar
APMC College of Pharmaceutical Education and Research,
Motipura, Himmatngar, Gujarat, India
tambolirushabh@gmail.com
ABSTRACT:
A specific, accurate, precise and reproducible RP-HPLC method has been developed and subsequently validated for the simultaneous determination of Ilaprazole and Domperidone in pharmaceutical dosage form. The proposed HPLC method utilizes hypersil (Thermo scientific) C18 column (250 mm × 4.6 mm id, 5 μm particle size), and mobile phase consisting of methanol:phosphate buffer (40:60) and pH adjusted to 4.0 with 0.1M glacial acetic acid at a flow rate of 1.0 mL/min. Quantitation was achieved with UV detection at 230 nm based on peak area with linear calibration curves at concentration ranges 5-15 μg/ml for Ilaprazole and 15-45 μg/ml for Domperidone. The retention time of Ilaprazole and Domperidone were found to be 3.433 min and 5.860 min respectively. The method was validated in terms of accuracy, precision, linearity, limits of detection, limits of quantitation and robustness. This method has been successively applied to marketed formulation and no interference from the formulation excipients was found.
How to cite this article: RA Tamboli, VC Chauhan, MM Pathan, SK Tirgar, DA Shah, RR Parmar; Development and Validation of RP-HPLC Method for Simultaneous Estimation of Ilaprazole and Domperidone in Pharmaceutical Dosage Form; PharmaTutor; 2014; 2(7); 149-156
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1.KD Tripathi: Essentials of Medical pharmacology. Japee Brothers,2004
2.Moffat AC; Osselton MD; Widdop B and Watts J. Clarke’s Analysis of Drugs and poisons in pharmaceuticals.London Pharmaceutical press, 2011.
3.Indian Pharmacopoeia, Volume-III, 6thEdn, The Indian Pharmacopoeia commission, Ghaziabad, Govt. of India, Ministry of Health and Family Welfare, 2010.
4.Drug Bank, “Ilaprazole ”, drugbank.ca/drugs/DB00384.
5.Joel G.H, Perry B.M, Lee E.L, Raymond W.R, Alfred Cg, editor., Goodman Gilman’s The pharmacological basis of Therapeutics, 9th ed. New Jersy: Mc-Graw Hill Companies, 1996.
6.Sweetman SC. Martindale: The complete drug reference. London Pharmaceutical Press, 2009.
7.Drug Bank, “Domperidone”, drugbank.ca/drugs/DB00562.
8.Mansuri BK, Faldu S and Dadhania K. "Estimation of Ilaprazole in bulk drug and its pharmaceutical dosage form by difference spectrophotometric method".
9.Adhiyar P, Bhati S, Patel H and Pancholi S. "Development and validation of a stability-indicating UV spectroscopic method for Ilaprazole in bulk and pharmaceutical formulations ". Inventi Rapid. 2013.
10.Mansuri JC, Hariyani H, Kanani B and Faldu S. "Development and validation of spectrophotometric method for the determination of Ilaprazole in bulk drug and its pharmaceutical dosage form ".
11.Padhiyar P, Padaliya H, B Sanjaysingh, Patel H and Pancholi S.S. "Development and validation of UV spectrophotometric method for estimation of Ilaprazole in bulk and pharmaceutical dosage form ". Inventi Rapid. 2013.
12.B.satheesh, D.sravanan and K.gundu. "Simultaneous determination of Ilaprazole and its related compound in pharmaceutical dosage form by UPLC". J. Liq. Chromatogr. Relat. Technol. 2013, 20, 2968-2981.
13.Zhou TZ, Zhang W, Ou-Yang DS, Chen Y, Guo D, Liu YZ, Fan L and Deng HW. "An improved LC-MS/MS method for quantitative determination of Ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study". Actapharmaconsin.,30, 2009, 1330-1336.
14.Shah R, Talavia B, Patel P, Tailor P and ShahS, AICTE Sponsored seminar on Quality Assurance Issues in Drug Discovery & Formulation Development. 2013,
15.Lakshamanaprabu As, shirwaikar A, C DK, Joseph A and kumar R. "Simultaneous determination of Esomeprazole and Domperidone by UV spectrophotometric method". Indian J. pharm sci., 70, 2008, 128-131.
16.Kalure SU, Kulkarni R and SomwanshiGP."Spectrometric simultaneous determination of Domperidone and Pantoprazole". Der. Pharm. Chemica. 2012, 4, 1517-1521.
17.Jadhav K, Dhamecha DL, Ghadlinge SV, Asnani GP and PatilMB,“Simultaneous determination of Lafutidine and Domperidone by ultraviolet spectroscopy". ISRN Anal. Chem.,2012, 2012, 1-4.
18.Kumar YD, V Ravinder and M Rajesh. "Simultaneous eastimation of Omeprazole magnesium and Domperidone tablets by ultraviolet spectroscopy". IJPS, 2, 2011, 207-210.
19.Kalra K, Naik S, Jarmal G and Mishra Y. "Spectrophotometric method for simultaneous estimation of Paracetamol and Domperidone in tablet formulation". Asian J. Research Chem., 2009, 2, 112-114.
20.Patel AH, Patel JK and Patel KN. "Development and validation of derivative spectrophotometric method for simultaneous estimation of Domperidone and Rabeprazole sodium in bulk and dosage forms". Int.J.Ph.Sci., 2010, 464-469.
21.Rana S , Pandya J, Solanki S and Patel M. "Development and Validation of Spectrophotometric method for Simultaneous estimation of Lafutidine and Domperidone in combined dosage form by area under curve method". Ijddr, 2012, 4, 257-262.
22.Tarkase KN, Tarkase MK, Dokhe MD and Wagh VS. "Development and validation of spectrophotometric method for simultaneous estimation of Cinnarizine and Domperidone maleate in pure and tablet dosage form".Ijpsr, 2012, 3, 2700-2704.
23.ICH Q1 A (R2): Stability Testing of New Drugs and Products. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, 2003.
24.ICH Q2 (R1): Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use, ICH Harmonised Tripartite Guideline, 2005.
.png)
